Is there significant regional variation in hospital antibiotic consumption in Germany?

Infection

Volumn 34, Issue 5, 2006, Pages 274-277

  De With, K ^a   Steib Bauert, M ^a   Straach, P ^b   Kern, W V ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b IQVIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFEPIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; FLUCLOXACILLIN; GLYCOPEPTIDE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN;

ANTIBIOTIC THERAPY; ARTICLE; DRUG USE; EUROPE; GEOGRAPHIC DISTRIBUTION; GERMANY; HOSPITAL CARE; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; PHARMACEUTICAL CARE; SURGICAL WARD; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; DRUG UTILIZATION; GERMANY; HOSPITALS; HUMANS;

EID: 33749837901     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-006-6617-z     Document Type: Article

References (15)

1. Harbarth S, Samore MH: Antimicrobial resistance determinants and future control. Emerg Infect Dis 2005; 11: 794-801.
2. Livermore DM: Minimising antibiotic resistance. Lancet Infect Dis 2005; 5: 450-459.
3. Vander Stichele RH, Elseviers M, Ferrech M, Blot S, Goossens H, ESAC Project Group: European surveillance of antimicrobial consumption (ESAC): data collection and methodological approach. Br J Clin Pharm 2004; 58: 419-428.
4. Goossens H, Matus F, Vander Stichele RH, Elseviers M, ESAC Project Group: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-549.
5. de With K, Schröder H, Meyer E, Nink K, Hoffmann S, Steib-Bauert M, Kämmerer R, Ruess S, Daschner FD, Kern WV: Antibiotikaanwendung in Deutschland im europäischen Vergleich. Dtsch Med Wochenschr 2004; 129: 1987-1992.
6. Kern WV, de With K, Nink K, Steib-Bauert M, Schröder H: Regional Variation in outpatient antibiotic prescribing in Germany. Infection 2006; 34: 269-273.
7. Gesundheitswesen - Grunddaten der Krankenhäuser und Vorsorge- oder Rehabilitationseinrichtungen 2003. Statistisches Bundesamt, Wiesbaden, 2005.
8. de With K, Bergner J, Bühner R, Dorje F, Gonnermann C, Haber M, Hartmann M, Rothe U, Strehl E, Steib-Bauert M, Kern WV: Antibiotic use in German university hospitals 1998-2000. Int J Antimicrob Agents 2004; 24: 213-218.
9. Kern WV, de With K, Steib-Bauert M, Fellhauer M, Plangger A, Probst W, MABUSE-INTERREGIO-II Project Team: Antibiotic use in non-university regional acute care general hospitals in southwestern Germany, 2001-2002. Infection 2005; 33: 333-339.
10. de With K, Meyer E, Steib-Bauert M, Schwab F, Daschner FD, Kern WV: Antibiotic use in two cohorts of German intensive care units, 2001-2002. J Hosp Infect 2006 (in press)
11. Rogues AM, Placet-Thomazeau B, Parneix P, Vincent I, Ploy MC, Marty N, Merillou B, Labadie JC, Gachie JP. Use of antibiotics in hospitals in south-western France. J Hosp Infect 2004; 58: 187-192.
12. SWEDRES 2003: A report on Swedish antibiotic utilisation and resistance in human medicine. ISSN 1400-3473. Swedish strategic programme for the rational use of antimicrobial agents (STRAMA) and the Swedish Institute for Infectious Disease Control, Solna, Sweden, 2003.
13. Blix HS, Hartug S: Hospital usage of antibacterial agents in relation to size and type of hospital and geographical situation. Pharmacoepidemiol Drug Saf 2005; 14: 647-649.
14. Muller-Pebody B, Muscat M, Pelle B, Klein BM, Brandt CT, Monnet DL: Increase and change in pattern of hospital antimicrobial use, Denmark, 1997-2001. J Antimicrob Chemother 2004; 54: 1122-1126.
15. Liem TB, Filius FM, van der Linden PD, Janknegt R, Natsch S, Vulto AG: Changes in antibiotic use in Dutch hospitals over a six-year period: 1997 to 2002. Neth J Med 2005; 63: 354-360.